Losartan Impurity 37 | CAS 1350088-07-1 - Request Quote
Losartan Impurity 37
| SZ CAT No: | SZ-L028078 |
| CAS No | 1350088-07-1 |
| Mol.F. | C22H21ClN6O2 |
| Mol.Wt. | 436.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Losartan Impurity 37 is chemically 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazole-4-carboxylic acid. Losartan Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Losartan Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1350088-07-1
Purchase 1350088-07-1
Order 1350088-07-1
Enquire 1350088-07-1
price of 1350088-07-1
1350088-07-1 Supplier
1350088-07-1 Manufacturer
1350088-07-1 Exporter
buy high quality Losartan Impurity 37
Purchase Losartan Impurity 37
Losartan Impurity 37 suppliers
Losartan Impurity 37 manufacturers
Losartan Impurity 37 price
Order Losartan Impurity 37
Enquire Losartan Impurity 37
Losartan Impurity 37 cost
Losartan Impurity 37 Supplier
Losartan Impurity 37 Distributor
Losartan Impurity 37 for Method Validation
Losartan Reference Standard
Losartan Impurity 37 for ANDA Filing
Losartan Impurity 37 for Forced Degradation Studies
Losartan Impurity 37 Identification Standards
Losartan Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.